The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Synthetic Blood Substitutes And Blood Products Market During The Forecast Period?
The synthetic blood substitutes and blood products market has experienced rapid expansion in recent years. Its valuation is set to rise from $7.6 billion in 2025 to $8.81 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. Historically, this expansion has been driven by factors including shortfalls in blood donations, the demand from trauma and surgical cases, the hazards of transfusion-transmitted infections, an increase in cardiovascular surgical procedures, and medical requirements for military personnel.
The market for synthetic blood substitutes and blood products is poised for significant expansion in the coming years. Its valuation is projected to reach $15.7 billion by 2030, advancing at a compound annual growth rate (CAGR) of 15.6%. This anticipated growth stems from factors such as an increase in trauma incidents, operations on an aging population, innovations in recombinant factors, the need for universal blood substitutes, and funding for emergency readiness. Prominent trends during this forecast period involve the development of oxygen-carrying blood substitutes, alternatives for emergency trauma blood, a diminished reliance on donor blood, the availability of blood products with extended shelf lives, and their incorporation into military and disaster medicine.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Synthetic Blood Substitutes And Blood Products Market Landscape?
The increasing occurrence of chronic diseases is anticipated to boost the growth of the synthetic blood substitutes and blood products market. Chronic conditions are enduring health issues that can be managed but not cured, frequently lasting a year or more and necessitating ongoing medical care. The rising prevalence of these diseases stems from several factors, including an aging population, unhealthy lifestyles, and increased life expectancy. Synthetic blood substitutes and blood products play a vital role in addressing challenges like blood loss, anaemia, and organ function, which are commonly experienced by patients with chronic ailments. For instance, according to the Office for Health Improvement & Disparities (OHID), a UK-based unit of the Department of Health and Social Care, the GP recorded type 2 diabetes prevalence in adults as 7.0% for those aged 17 and over in England in March 2024, which marked an increase from 6.8% in March 2023, as reported in March 2025. Consequently, the growing prevalence of chronic diseases is a significant factor driving the expansion of the synthetic blood substitutes and blood products market.
What Segment Categories Shape The Synthetic Blood Substitutes And Blood Products Market Segment Landscape?
The synthetic blood substitutes and blood products market covered in this report is segmented –
1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users
Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions
What Market Trends Are Affecting The Synthetic Blood Substitutes And Blood Products Market?
Major companies operating in the synthetic blood substitutes and blood products market are focusing on developing innovative products, such as lab-grown blood vessels, to enhance emergency medical care, improve trauma treatment outcomes, and address the global shortage of donor blood and tissues. Lab-grown blood vessels are artificial blood conduits engineered from human or synthetic cells, designed to replicate the structure and function of natural arteries and veins for medical applications such as trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology platform company, received US Food and Drug Administration (FDA) approval for Symvess, an off-the-shelf, bioengineered blood vessel implant for trauma patients needing urgent revascularization, offering a safer alternative to vein harvesting or synthetic grafts. Symvess, designed for universal use, restores blood flow and preserves limbs after severe injuries.
Who Are The Companies Operating Across The Synthetic Blood Substitutes And Blood Products Market Value Chain?
Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.
Get The Full Synthetic Blood Substitutes And Blood Products Market Report:
Which Region Is The Top Contributor To The Synthetic Blood Substitutes And Blood Products Market By Share?
North America was the largest region in the synthetic blood substitutes and blood products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Synthetic Blood Substitutes And Blood Products Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Synthetic Blood Substitutes And Blood Products Market 2026, By The Business Research Company
Blood Processing Devices And Consumables Market Report 2026
Blood Preparation Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report
Blood Plasma Derivatives Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model